Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
by Egberts, Friederike (Author)
, Gutzmer, R. (Author)
, Ugurel, S. (Author)
, Becker, J. C. (Author)
, Trefzer, U. (Author)
, Degen, A. (Author)
, Schenck, F. (Author)
, Frey, L. (Author)
, Wilhelm, T. (Author)
, Hassel, Jessica C. (Author)
, Schadendorf, D. (Author)
, Livingstone, E. (Author)
, Mauch, C. (Author)
, Garbe, C. (Author)
, Berking, C. (Author)
, Rass, K. (Author)
, Mohr, P. (Author)
, Kaehler, K. C. (Author)
, Weichenthal, M. (Author)
, Hauschild, A. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource